Generation of insulin-producing hepatocyte-like cells from human Wharton's jelly mesenchymal stem cells as an alternative source of islet cells

Journal of Cellular Physiology
Leila BeikmohammadiBahram Kazemi

Abstract

Islet cell transplantation, as a treatment of type 1 diabetes, has a lot of complexity such as allograft rejections and an insufficient number of donors. The liver can be used as a replacement for endogenous insulin production. Hepatocytes can inherently respond to glucose levels and secrete proteins. Utilization of mesenchymal stem cells for curing diabetes represents a major focus of recent investigations. As a new choice for transplantation, we have proposed glucose-regulated insulin-producing hepatocyte-like cells, which produce insulin dependent on glucose levels. We have transfected human Wharton's jelly mesenchymal stem cells with the special construct, which included homology arms and glucose-responsive elements upstream of the minimum liver-type pyruvate kinase promoter-directed insulin gene. Then, we have differentiated these transfected cells to hepatocyte-like cells by using serial exposure of different inducing material and exogenous growth factors. Immunofluorescence analyses have demonstrated the expression of albumin, cytokeratin-18, Hep-Par1, α-fetoprotein, and insulin. The expression of hepatocyte marker genes in the differentiated cells was confirmed by reverse-transcription polymerase chain reaction. Interes...Continue Reading

References

Jun 1, 1995·The Journal of Cell Biology·R Zarnegar, G K Michalopoulos
Aug 1, 1994·Endocrine Reviews·J F Bach
Dec 23, 1993·Biochimica Et Biophysica Acta·J S RubinS A Aaronson
Sep 17, 1998·The Journal of Biological Chemistry·C GregoriA L Pichard
Dec 19, 2000·Biochemical and Biophysical Research Communications·S H OhM Namba
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·H YamashitaK Uyeda
Dec 19, 2001·The Journal of Biological Chemistry·Donald B Jump
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Jeffrey C StevensMatthew J Zaya
Sep 27, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Philipp C NettTausif Alam
May 4, 2004·Annales d'endocrinologie·B Thorens
Nov 25, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kuan-Der LeeOscar Kuang-Sheng Lee
Feb 1, 2005·Journal of Autoimmune Diseases·Muhammad T TabiinBernard E Tuch
Sep 29, 2006·World Journal of Gastroenterology : WJG·Raquel Taléns-ViscontiMaría José Gómez-Lechón
Dec 7, 2007·Biotechnology & Genetic Engineering Reviews·Matthew Porteus
Feb 20, 2008·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·D D LeeA S Chong
Mar 14, 2008·Toxicologic Pathology·Ana P Cotrim, Bruce J Baum
Jul 8, 2011·Placenta·R R TaghizadehC L Cetrulo
Apr 10, 2012·Annals of Biomedical Engineering·Shan GaoMartin L Yarmush
Feb 22, 2013·Nature Protocols·Nicholas R F HannanLudovic Vallier
Jul 4, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Karolien BuylTamara Vanhaecke
Jan 21, 2014·Biochemical and Biophysical Research Communications·Tadashige Nozaki, Kiyoshi Ohura
Feb 21, 2014·Tissue Engineering. Part B, Reviews·Reine El OmarVeronique Decot
Dec 11, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Zhongchun SuXing Wei
Jun 2, 2015·Molecular Therapy. Methods & Clinical Development·Janet LawandiAnn M Simpson
Jan 7, 2016·Nature Communications·Saiyong ZhuSheng Ding
Jan 23, 2016·Nature·Jinghui ZhaoAlfred L Goldberg
Jul 19, 2016·International Journal of Stem Cells·Shabari Sarang, Chandra Viswanathan
Mar 1, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Seyed Ehsan EnderamiHassan Askari

❮ Previous
Next ❯

Citations

May 19, 2019·Molecular Biology Reports·Shuvasree SarkarShelley Bhattacharya
Dec 16, 2019·Drug Discovery Today·Labe Black, Tatiana Zorina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.